Fig. 6
- ID
 - ZDB-FIG-230424-73
 - Publication
 - Athapaththu et al., 2022 - Pinostrobin ameliorates lipopolysaccharide (LPS)-induced inflammation and endotoxemia by inhibiting LPS binding to the TLR4/MD2 complex
 - Other Figures
 - All Figure Page
 - Back to All Figure Page
 
| 
            
    
    
    
            
            
            
            
                
                    
                    
                        
                        
                        
                            
                            
 Pinostrobin recovers heart rate and attenuates mortality and abnormality in LPS-microinjected zebrafish larvae. Zebrafish larvae at 3 dpf (n = 20) were microinjected with 2 nL of 0.5 mg/mL LPS and immediately treated with the indicated concentrations of pinostrobin (0–20 μM). (A) After 24 h (at 4 dpf), heart rate was measured by manually counting heartbeats per minute to assess cardiotoxicity. ###, p < 0.001 vs. untreated zebrafish larvae; **, p < 0.01 and ***, p < 0.001 vs. LPS-microinjected zebrafish larvae. (B) Phenotype-based evaluations were performed 48 h (at 5 dpf) after LPS microinjection. LPS microinjection increases abnormalities in zebrafish larvae; normal, death, cyrtosis, yolk necrosis, yolk sac edema yolk crenulation, pericardial edema, and head malformation. (C) LPS microinjection induced 50% abnormalities in zebrafish larvae (left), and pinostrobin (20 μM)-treated zebrafish reduced the abnormality to 10% (right).  |